Last 7 days
-1.4%
Last 30 days
-16.9%
Last 90 days
-7.3%
Trailing 12 Months
-54.1%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
HCA | 70.6B | 60.2B | -4.86% | -6.89% | 12.5 | 1.17 | 2.52% | -18.88% |
CERN | 27.9B | - | 0.98% | 20.75% | 47.36 | 4.81 | - | - |
VEEV | 27.3B | 2.1B | -0.47% | -1.83% | 68.93 | 13.15 | 17.88% | -8.53% |
LH | 19.6B | 14.9B | -11.65% | -18.57% | 15.35 | 1.32 | -7.72% | -46.20% |
MID-CAP | ||||||||
CHNG | 9.0B | 3.5B | 11.88% | 31.28% | -116.8 | 2.57 | 7.15% | -34.72% |
TDOC | 4.1B | 2.4B | -16.92% | -54.15% | -0.3 | 1.71 | 18.41% | -3085.58% |
OMCL | 2.5B | 1.3B | 1.97% | -58.05% | 451.35 | 1.97 | 14.48% | -92.74% |
SMALL-CAP | ||||||||
PHR | 1.8B | 262.3M | -10.85% | 40.30% | -9.92 | 6.98 | 33.16% | -131.28% |
MDRX | 1.5B | 837.2M | -24.90% | -38.38% | 24.16 | 1.75 | 3.88% | -92.18% |
NXGN | 1.1B | 625.9M | -11.35% | -14.10% | 49.5 | 1.81 | 6.21% | 3223.77% |
SLP | 864.4M | 53.5M | 4.26% | 2.91% | 80.77 | 16.17 | 10.94% | 3.61% |
HCAT | 657.1M | 276.2M | -14.12% | -43.94% | -4.78 | 2.38 | 14.18% | 10.32% |
OPRX | 234.3M | 63.1M | -26.73% | -64.73% | -22.34 | 3.71 | 9.93% | -1043.45% |
TRHC | 155.2M | 357.1M | -7.94% | 20.85% | -1.11 | 0.43 | 33.22% | -57.66% |
WORX | 4.6M | 4.3M | -19.40% | -50.10% | -1.89 | 1.09 | -12.25% | 9.68% |
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 3.6% | 2,406,840,000 | 2,323,366,000 | 2,233,622,000 | 2,144,382,000 | 2,032,707,000 |
S&GA Expenses | -1.3% | 227,172,000 | 230,223,000 | 238,191,000 | 244,117,000 | 250,581,000 |
R&D Expenses | 1.4% | 333,629,000 | 328,920,000 | 321,355,000 | 321,288,000 | 311,884,000 |
EBITDA | -38.4% | -13,437,351,000 | -9,709,548,000 | -9,743,248,000 | -6,795,388,000 | - |
EBITDA Margin | -33.6% | -5.58 | -4.18 | -4.36 | -3.17 | - |
Earnings Before Taxes | -37.8% | -13,663,343,000 | -9,912,157,000 | -9,918,207,000 | -6,946,181,000 | -384,656,000 |
EBT Margin | -33.1% | -5.68 | -4.27 | -4.44 | -3.24 | - |
Interest Expenses | 36.9% | -30,035,000 | -47,584,000 | -63,720,000 | -80,365,000 | - |
Net Income | -38.5% | -13,659,531,000 | -9,860,445,000 | -9,871,309,000 | -6,903,667,000 | -428,793,000 |
Net Income Margin | -33.7% | -5.68 | -4.24 | -4.42 | -3.22 | - |
Free Cahsflow | -10.8% | 172,812,000 | 193,743,000 | 209,937,000 | 169,937,000 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | -46.4% | 4,345 | 8,104 | 8,103 | 11,092 | 17,735 |
Current Assets | 2.2% | 1,315 | 1,288 | 1,257 | 1,208 | 1,225 |
Cash Equivalents | 2.1% | 918 | 900 | 881 | 836 | 893 |
Inventory | -5.1% | 56.00 | 59.00 | 60.00 | 71.00 | 73.00 |
Net PPE | 8.7% | 30.00 | 27.00 | 27.00 | 28.00 | 27.00 |
Goodwill | -77.9% | 1,073 | 4,846 | 4,858 | 7,900 | 14,504 |
Current Liabilities | -2.8% | 400 | 411 | 371 | 307 | 331 |
LT Debt, Current | - | - | - | - | - | - |
Shareholder's Equity | -61.9% | 2,308 | 6,053 | 6,085 | 9,143 | 16,046 |
Retained Earnings | -34.0% | -15,008 | -11,198 | -11,124 | -8,023 | -1,421 |
Additional Paid-In Capital | 0.3% | 17,359 | 17,300 | 17,239 | 17,177 | 17,473 |
Shares Outstanding | 0.4% | 163 | 162 | 162 | 161 | 160 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -8.5% | 189 | 207 | 221 | 180 | 194 |
Share Based Compensation | -4.7% | 218 | 229 | 245 | 277 | 303 |
Cashflow From Investing | -25.2% | -167 | -133 | -127 | -84.52 | -72.98 |
Cashflow From Financing | -25.7% | 6.00 | 9.00 | 9.00 | 22.00 | 41.00 |
96.2%
60.4%
54.2%
Y-axis is the maximum loss one would have experienced if Teladoc was unfortunately bought at previous high price.
11.6%
-9.5%
-42.0%
FIve years rolling returns for Teladoc.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-10 | BAILLIE GIFFORD & CO | reduced | -9.49 | -20,689,500 | 112,272,000 | 0.12% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -0.05 | -30,453 | 416,547 | -% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -20.85 | -52,000 | 144,000 | -% |
2023-03-02 | OLIVER LAGORE VANVALIN INVESTMENT GROUP | unchanged | - | -1,640 | 24,360 | 0.01% |
2023-02-28 | Voya Investment Management LLC | reduced | -0.66 | -47,439 | 594,561 | -% |
2023-02-24 | BBJS FINANCIAL ADVISORS, LLC | new | - | 591 | 591 | -% |
2023-02-24 | SRS Capital Advisors, Inc. | reduced | -0.36 | -1,040 | 12,960 | -% |
2023-02-24 | National Pension Service | unchanged | - | -57.00 | 520 | -% |
2023-02-24 | NATIXIS | reduced | -95.59 | -15,871,700 | 680,316 | -% |
2023-02-22 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | sold off | -100 | -756,000 | - | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | vanguard group inc | 8.94% | 14,476,155 | SC 13G/A | |
Feb 07, 2023 | blackrock inc. | 6.2% | 9,961,219 | SC 13G/A | |
Feb 03, 2023 | sumitomo mitsui trust holdings, inc. | 5.01% | 8,125,231 | SC 13G/A | |
Jul 05, 2022 | baillie gifford & co | 4.80% | 7,739,623 | SC 13G/A | |
Mar 11, 2022 | blackrock inc. | 5.9% | 9,485,340 | SC 13G/A | |
Feb 14, 2022 | nikko asset management americas, inc. | 5.47% | 8,755,058 | SC 13G | |
Feb 09, 2022 | ark investment management llc | 11.82% | 18,922,198 | SC 13G/A | |
Feb 08, 2022 | blackrock inc. | 5.9% | 9,485,340 | SC 13G | |
Feb 04, 2022 | sumitomo mitsui trust holdings, inc. | 5.70% | 9,140,808 | SC 13G | |
Jan 26, 2022 | baillie gifford & co | 6.79% | 10,877,063 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 2.78 -88.98% | 6.06 -75.97% | 16.14 -36.00% | 34.85 38.18% | 72.42 187.15% |
Current Inflation | 2.54 -89.93% | 5.45 -78.39% | 14.21 -43.66% | 30.24 19.90% | 62.23 146.75% |
Very High Inflation | 2.24 -91.12% | 4.72 -81.28% | 11.93 -52.70% | 24.86 -1.43% | 50.47 100.12% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 07, 2023 | 4 | Insider Trading | |
Mar 07, 2023 | 4 | Insider Trading | |
Mar 07, 2023 | 4 | Insider Trading | |
Mar 07, 2023 | 4 | Insider Trading | |
Mar 07, 2023 | 4 | Insider Trading | |
Mar 07, 2023 | 4 | Insider Trading | |
Mar 07, 2023 | 4 | Insider Trading | |
Mar 07, 2023 | 4 | Insider Trading | |
Mar 07, 2023 | 4 | Insider Trading | |
Mar 07, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-03 | Vandervoort Adam C | sold | -132,042 | 25.911 | -5,096 | chief legal officer, secretary |
2023-03-03 | GOREVIC JASON N | sold | -571,078 | 25.911 | -22,040 | chief executive officer |
2023-03-03 | Verstraete Stephany | sold | -74,442 | 25.911 | -2,873 | chief marketing officer |
2023-03-03 | Murthy Mala | sold | -192,726 | 25.911 | -7,438 | chief financial officer |
2023-03-03 | Turitz Andrew | sold | -46,510 | 25.911 | -1,795 | svp - corporate development |
2023-03-03 | Trencher Daniel | sold | -47,624 | 25.911 | -1,838 | svp corporate strategy |
2023-03-02 | Murthy Mala | sold | -192,878 | 25.362 | -7,605 | chief financial officer |
2023-03-02 | Jensen Claus Torp | sold | -85,926 | 25.362 | -3,388 | chief innovation officer |
2023-03-02 | GOREVIC JASON N | acquired | - | - | 44,814 | chief executive officer |
2023-03-02 | Verstraete Stephany | acquired | - | - | 8,102 | chief marketing officer |
Consolidated Statements of Operations and Other Comprehensive Loss - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Consolidated Statements of Operations and Other Comprehensive Loss | |||
Revenue | $ 2,406,840 | $ 2,032,707 | $ 1,093,962 |
Expenses: | |||
Cost of revenue (exclusive of depreciation and amortization, which is shown separately below) | 743,987 | 650,258 | 390,829 |
Operating expenses: | |||
Advertising and marketing | 623,536 | 416,726 | 226,146 |
Sales | 227,172 | 250,581 | 154,052 |
Technology and development | 333,629 | 311,884 | 164,941 |
General and administrative | 449,855 | 438,007 | 506,684 |
Acquisition, integration, and transformation costs | 15,620 | 26,643 | 88,236 |
Restructuring costs | 7,416 | 0 | 0 |
Depreciation and amortization | 256,027 | 204,239 | 69,495 |
Goodwill impairment | 13,402,812 | 0 | 0 |
Total expenses | 16,060,054 | 2,298,338 | 1,600,383 |
Loss from operations | (13,653,214) | (265,631) | (506,421) |
Loss on extinguishment of debt | 0 | 43,748 | 9,077 |
Other expense (income), net | 859 | (5,088) | 545 |
Interest expense, net | 9,270 | 80,365 | 59,950 |
Loss before provision for income taxes | (13,663,343) | (384,656) | (575,993) |
Provision for income taxes | (3,812) | 44,137 | (90,857) |
Net loss | (13,659,531) | (428,793) | (485,136) |
Other comprehensive income (loss), net of tax: | |||
Currency translation adjustment and other | (36,491) | (24,803) | 35,757 |
Comprehensive loss | $ (13,696,022) | $ (453,596) | $ (449,379) |
Net loss per share, basic (in dollars per share) | $ (84.60) | $ (2.73) | $ (5.36) |
Net loss per share, diluted (in dollars per share) | $ (84.60) | $ (2.73) | $ (5.36) |
Weighted-average shares used to compute basic net loss per share | 161,457,123 | 156,939,349 | 90,509,229 |
Weighted-average shares used to compute diluted net loss per share | 161,457,123 | 156,939,349 | 90,509,229 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 918,182 | $ 893,480 |
Short-term investments | 0 | 2,537 |
Accounts receivable, net of allowance of $14,800 and $12,384, respectively | 210,554 | 168,956 |
Inventories | 56,342 | 73,079 |
Prepaid expenses and other current assets | 130,310 | 87,387 |
Total current assets | 1,315,388 | 1,225,439 |
Property and equipment, net | 29,641 | 27,234 |
Goodwill | 1,073,190 | 14,504,174 |
Intangible assets, net | 1,836,765 | 1,910,278 |
Operating lease - right-of-use assets | 41,831 | 46,780 |
Other assets | 48,540 | 20,703 |
Total assets | 4,345,355 | 17,734,608 |
Current liabilities: | ||
Accounts payable | 47,690 | 47,257 |
Accrued expenses and other current liabilities | 168,693 | 102,933 |
Accrued compensation | 81,554 | 91,941 |
Deferred revenue-current | 90,457 | 75,569 |
Advances from financing companies | 11,375 | 13,313 |
Total current liabilities | 399,769 | 331,013 |
Other liabilities | 1,618 | 1,492 |
Operating lease liabilities, net of current portion | 38,042 | 41,773 |
Deferred revenue, net of current portion | 3,872 | 3,834 |
Advances from financing companies, net of current portion | 8,082 | 9,291 |
Deferred taxes, net | 50,939 | 75,777 |
Convertible senior notes, net | 1,535,288 | 1,225,671 |
Commitments and contingencies (Note 13) | ||
Stockholders' equity: | ||
Common stock, $0.001 par value; 300,000,000 shares authorized; 162,840,360 shares and 160,469,325 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively | 163 | 160 |
Additional paid-in capital | 17,358,645 | 17,473,336 |
Accumulated deficit | (15,008,287) | (1,421,454) |
Accumulated other comprehensive loss | (42,776) | (6,285) |
Total stockholders' equity | 2,307,745 | 16,045,757 |
Total liabilities and stockholders' equity | $ 4,345,355 | $ 17,734,608 |